L M Delbridge1, A G Stewart, C M Goulter
1Department of Physiology, University of Melbourne, Parkville, Victoria, Australia.
Platelet-activating factor (PAF) directly reduces adult cardiomyocyte contractility via receptor-mediated pathways. A PAF antagonist, WEB-2086, blocks this effect and enhances contractility independently.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: